Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells
Molecules · 2023
DOI: 10.3390/molecules28207205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lufen Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jining Medical University, Rizhao 276500, China. Hauptthemen laut MEDLINE: Apoptosis, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Macao Science and Technology Development Fund of Macao SAR.
Abstract (Originalsprache)
Pancreatic cancer remains a formidable challenge in oncology due to its aggressive nature and limited treatment options. In this study, we investigate the potential therapeutic efficacy of elaiophylin, a novel compound, in targeting BxPC-3 and PANC-1 pancreatic cancer cells. We comprehensively explore elaiophylin’s impact on apoptosis induction, proliferation inhibition, migration suppression, invasion attenuation, and angiogenesis inhibition, key processes contributing to cancer progression and metastasis. The results demonstrate that elaiophylin exerts potent pro-apoptotic effects, inducing a substantial increase in apoptotic cells. Additionally, elaiophylin significantly inhibits proliferation, migration, and invasion of BxPC-3 and PANC-1 cells. Furthermore, elaiophylin exhibits remarkable anti-angiogenic activity, effectively disrupting tube formation in HUVECs. Moreover, elaiophylin significantly inhibits the Wnt/β-Catenin signaling pathway. Our findings collectively demonstrate the multifaceted potential of elaiophylin as a promising therapeutic agent against pancreatic cancer via inhibition of the Wnt/β-Catenin signaling pathway. By targeting diverse cellular processes crucial for cancer progression, elaiophylin emerges as a prospective candidate for future targeted therapies. Further investigation of the in vivo efficacy of elaiophylin is warranted, potentially paving the way for novel and effective treatment approaches in pancreatic cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jining Medical University, Rizhao 276500, China.
- Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou 646000, Chi…
ORCID-Profile: Lufen Huang, Anguo Wu
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Macao Science and Technology Development Fund of Macao SAR
- Southwest Medical University
- Shandong Science and Technology Program
Zitieren
APA
Huang, L., Liu, Y., Pan, Y., Liu, C., Gao, H., Ren, Q., Wang, J., Wang, H., Zhang, Y., & Wu, A. (2023). Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells. Molecules. https://doi.org/10.3390/molecules28207205
Vancouver
Huang L, Liu Y, Pan Y, Liu C, Gao H, Ren Q, et al. Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells. Molecules. 2023. doi:10.3390/molecules28207205
BibTeX
@article{Huang2023,
author = {Huang, Lufen and Liu, Yufeng and Pan, Yiru and Liu, Chao and Gao, Huijie and Ren, Qiang and Wang, Jianan and Wang, Huiyun and Zhang, Yuntao and Wu, Anguo},
title = {Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic Cancer Cells},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28207205}
}
EUVIMED